Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
NF2 mutation
i
Other names:
Nf2, Merlin
Associations
(7)
News
Trials
C3 | Sensitive
C4 | Sensitive
D | Sensitive
C3 | Resistant
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Tyrosine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Threonine-Tyrosine Kinase Inhibitors
EGFR
Serine-Threonine Kinase Inhibitors
PI3 Kinase Inhibitors
Other
Cancel
Breast Cancer
Thyroid Gland Anaplastic Carcinoma
Renal Cell Carcinoma
Meningioma
Kidney Medullary Carcinoma
Mesothelioma
bevacizumab
C3
NF2 mutation
|
Breast Cancer
|
bevacizumab
atezolizumab + cobimetinib
C3
NF2 mutation
|
Thyroid Gland Anaplastic Carcinoma
|
atezolizumab + cobimetinib
nivolumab + cabozantinib tablet
C3
NF2 mutation
|
Renal Cell Carcinoma
|
nivolumab + cabozantinib tablet
GSK2256098
C3
NF2 mutation
|
Meningioma
|
GSK2256098
bevacizumab + erlotinib
C4
NF2 mutation
|
Kidney Medullary Carcinoma
|
bevacizumab + erlotinib
CBL0102
D
NF2 mutation
|
Mesothelioma
|
CBL0102
verteporfin
D
NF2 mutation
|
Mesothelioma
|
verteporfin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
